Glucose stimulated CEST MRI pHe mapping for improved differentiation of tumors with altered hypoxia inducible factor 1alpha expression
Abstract Identification of highly aggressive tumors from benign phenotypes is an important diagnostic need, with increased expression of hypoxia-inducible factor-1α (HIF-1α) as one factor linked to tumor progression and treatment response. HIF-1α stabilization is closely linked to extracellular pH (...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-14102-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849237867727945728 |
|---|---|
| author | Aruna Singh Julia Stabinska Balaji Krishnamachary Farzad Sedaghat Sridhar Nimmagadda Jeff W. M. Bulte Zaver M. Bhujwalla Michael T. McMahon |
| author_facet | Aruna Singh Julia Stabinska Balaji Krishnamachary Farzad Sedaghat Sridhar Nimmagadda Jeff W. M. Bulte Zaver M. Bhujwalla Michael T. McMahon |
| author_sort | Aruna Singh |
| collection | DOAJ |
| description | Abstract Identification of highly aggressive tumors from benign phenotypes is an important diagnostic need, with increased expression of hypoxia-inducible factor-1α (HIF-1α) as one factor linked to tumor progression and treatment response. HIF-1α stabilization is closely linked to extracellular pH (pHe) through the regulation of glycolysis, proton transporters and vascular endothelial growth factor (VEGF). Magnetic resonance imaging (MRI)—based pHe measurement has shown promise in differentiating tumor phenotypes. In this study, we evaluated a new protocol designed to enhance tumor acidosis by administering glucose prior to pHe measurements in orthotopic human breast cancer xenografts. To demonstrate the utility of this approach, we used human triple-negative breast cancer (TNBC) MDA-MB-231 cells that were either wild type (231-WT) or genetically engineered to stably express short hairpin RNA (shRNA) against HIF-1α (231-HIF-1α-shRNA) or engineered to overexpress VEGF (231-VEGF). Iopamidol was administered for chemical exchange saturation transfer (CEST) MRI pHe mapping. We observed enhanced differentiation in the pHe maps following glucose administration, with mean pHe of 6.1 ± 0.12 (231-WT), 6.3 ± 0.04 (231-VEGF) and 6.58 ± 0.04 (231-HIF-1α-shRNA). Without glucose stimulation, the corresponding values were 6.31 ± 0.04 (231-WT), 6.30 ± 0.07 (231-VEGF), and 6.55 ± 0.04 (231-HIF-1α-shRNA). These findings were validated by immunoblotting and immunohistochemistry. Collectively our data demonstrate that CEST MRI pHe mapping can effectively differentiates tumors with low HIF-1α expression and that glucose stimulation enhances this differentiation, offering a valuable tool for improved tumor characterization. |
| format | Article |
| id | doaj-art-a1715b70100e45c08bcc7f39e416ebfc |
| institution | Kabale University |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-a1715b70100e45c08bcc7f39e416ebfc2025-08-20T04:01:51ZengNature PortfolioScientific Reports2045-23222025-08-0115111410.1038/s41598-025-14102-zGlucose stimulated CEST MRI pHe mapping for improved differentiation of tumors with altered hypoxia inducible factor 1alpha expressionAruna Singh0Julia Stabinska1Balaji Krishnamachary2Farzad Sedaghat3Sridhar Nimmagadda4Jeff W. M. Bulte5Zaver M. Bhujwalla6Michael T. McMahon7F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger InstituteF.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger InstituteRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of MedicineRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of MedicineRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of MedicineRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of MedicineRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of MedicineF.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger InstituteAbstract Identification of highly aggressive tumors from benign phenotypes is an important diagnostic need, with increased expression of hypoxia-inducible factor-1α (HIF-1α) as one factor linked to tumor progression and treatment response. HIF-1α stabilization is closely linked to extracellular pH (pHe) through the regulation of glycolysis, proton transporters and vascular endothelial growth factor (VEGF). Magnetic resonance imaging (MRI)—based pHe measurement has shown promise in differentiating tumor phenotypes. In this study, we evaluated a new protocol designed to enhance tumor acidosis by administering glucose prior to pHe measurements in orthotopic human breast cancer xenografts. To demonstrate the utility of this approach, we used human triple-negative breast cancer (TNBC) MDA-MB-231 cells that were either wild type (231-WT) or genetically engineered to stably express short hairpin RNA (shRNA) against HIF-1α (231-HIF-1α-shRNA) or engineered to overexpress VEGF (231-VEGF). Iopamidol was administered for chemical exchange saturation transfer (CEST) MRI pHe mapping. We observed enhanced differentiation in the pHe maps following glucose administration, with mean pHe of 6.1 ± 0.12 (231-WT), 6.3 ± 0.04 (231-VEGF) and 6.58 ± 0.04 (231-HIF-1α-shRNA). Without glucose stimulation, the corresponding values were 6.31 ± 0.04 (231-WT), 6.30 ± 0.07 (231-VEGF), and 6.55 ± 0.04 (231-HIF-1α-shRNA). These findings were validated by immunoblotting and immunohistochemistry. Collectively our data demonstrate that CEST MRI pHe mapping can effectively differentiates tumors with low HIF-1α expression and that glucose stimulation enhances this differentiation, offering a valuable tool for improved tumor characterization.https://doi.org/10.1038/s41598-025-14102-zChemical exchange saturation transfer (CEST)pHeHypoxia inducible factor-1α (HIF-1α)IopamidolBreast cancer |
| spellingShingle | Aruna Singh Julia Stabinska Balaji Krishnamachary Farzad Sedaghat Sridhar Nimmagadda Jeff W. M. Bulte Zaver M. Bhujwalla Michael T. McMahon Glucose stimulated CEST MRI pHe mapping for improved differentiation of tumors with altered hypoxia inducible factor 1alpha expression Scientific Reports Chemical exchange saturation transfer (CEST) pHe Hypoxia inducible factor-1α (HIF-1α) Iopamidol Breast cancer |
| title | Glucose stimulated CEST MRI pHe mapping for improved differentiation of tumors with altered hypoxia inducible factor 1alpha expression |
| title_full | Glucose stimulated CEST MRI pHe mapping for improved differentiation of tumors with altered hypoxia inducible factor 1alpha expression |
| title_fullStr | Glucose stimulated CEST MRI pHe mapping for improved differentiation of tumors with altered hypoxia inducible factor 1alpha expression |
| title_full_unstemmed | Glucose stimulated CEST MRI pHe mapping for improved differentiation of tumors with altered hypoxia inducible factor 1alpha expression |
| title_short | Glucose stimulated CEST MRI pHe mapping for improved differentiation of tumors with altered hypoxia inducible factor 1alpha expression |
| title_sort | glucose stimulated cest mri phe mapping for improved differentiation of tumors with altered hypoxia inducible factor 1alpha expression |
| topic | Chemical exchange saturation transfer (CEST) pHe Hypoxia inducible factor-1α (HIF-1α) Iopamidol Breast cancer |
| url | https://doi.org/10.1038/s41598-025-14102-z |
| work_keys_str_mv | AT arunasingh glucosestimulatedcestmriphemappingforimproveddifferentiationoftumorswithalteredhypoxiainduciblefactor1alphaexpression AT juliastabinska glucosestimulatedcestmriphemappingforimproveddifferentiationoftumorswithalteredhypoxiainduciblefactor1alphaexpression AT balajikrishnamachary glucosestimulatedcestmriphemappingforimproveddifferentiationoftumorswithalteredhypoxiainduciblefactor1alphaexpression AT farzadsedaghat glucosestimulatedcestmriphemappingforimproveddifferentiationoftumorswithalteredhypoxiainduciblefactor1alphaexpression AT sridharnimmagadda glucosestimulatedcestmriphemappingforimproveddifferentiationoftumorswithalteredhypoxiainduciblefactor1alphaexpression AT jeffwmbulte glucosestimulatedcestmriphemappingforimproveddifferentiationoftumorswithalteredhypoxiainduciblefactor1alphaexpression AT zavermbhujwalla glucosestimulatedcestmriphemappingforimproveddifferentiationoftumorswithalteredhypoxiainduciblefactor1alphaexpression AT michaeltmcmahon glucosestimulatedcestmriphemappingforimproveddifferentiationoftumorswithalteredhypoxiainduciblefactor1alphaexpression |